HONcode Certified

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

Bloggers

Carl Heneghan

Carl Heneghan

Deputy Director of the CEBM, GP and clinical lecturer at the University of Oxford.

Ami Banerjee

Ami Banerjee

Cardiology trainee and clinical research fellow at the University of Oxford

Carl Heneghan in action

CEBM Workshops Video Sample - Carl Heneghan - Diagnostic Tests

See Carl Heneghan in action in the CEBM's workshop videos.
Click here

Twitter TrustTheEvidence.net

Search the TRIP Database

TRIP Database


Recent comments

BMJ

18th August 2009 11:36am

Carl Heneghan and Matthew Thompson on Tamiflu in children: what’s all the fuss?   Carl Heneghan

This blog was first posted on the BMJ site.

Carl Heneghan:

The last few days has been hectic since the publication of our systematic review in the BMJ on the use of antivirals in children. By now, you are probably aware of the findings given the media interest. Basically, our study raised questions about the usefulness of antiviral flu drugs in preventing and treating flu in children, indicating the harmful effects may not be justified by the limited benefits provided. This puts us in direct conflict with the DOH policy of antivirals for all. I think what is important in the present pandemic is to remember how we spent a number of years preventing a similar strategy with the use of antibiotics in sore throat; especially when the published research showed limited benefits in mild disease and the emergence of resistance became a real issue. We have been slightly overwhelmed by all the media but are trying to keep a cool head. Having just come out of an interview on the Becky Anderson Show on CNN live at 9 o’clock on Wednesday there are a couple of things I have learnt over the last few days that have been helpful.

Read full article


Syndicate content